Avidity Partners Discloses 9.9% Stake in Immunic (IMUX)

TL;DR

**Avidity Partners just bought a huge chunk of Immunic, signaling big institutional confidence.**

AI Summary

Avidity Partners Management LP, an investment firm based in Dallas, TX, has disclosed a significant stake in Immunic, Inc. (IMUX), a pharmaceutical company. As of January 4, 2024, Avidity Partners beneficially owns 8,899,418 shares of Immunic's common stock, representing 9.9% of the company's outstanding shares. This substantial holding indicates Avidity Partners' strong conviction in Immunic's future, which could signal potential upside for current and prospective investors.

Why It Matters

This filing reveals a major institutional investor's confidence in Immunic, potentially boosting investor sentiment and signaling future growth prospects for the stock.

Risk Assessment

Risk Level: low — The filing indicates a significant institutional investment, which generally reduces perceived risk due to professional due diligence.

Analyst Insight

A smart investor would research Avidity Partners' investment thesis for Immunic and consider if this institutional backing aligns with their own investment strategy, potentially initiating or adding to a position.

Key Numbers

• 8,899,418 — Shares Beneficially Owned (Represents Avidity Partners' total holding in Immunic, Inc.)
• 9.9% — Percentage of Class Outstanding (Indicates Avidity Partners' significant influence over Immunic, Inc.)
• January 4, 2024 — Date of Event (The specific date when Avidity Partners' ownership crossed the reporting threshold.)

Key Players & Entities

• Avidity Partners Management LP (company) — reporting person, investment firm
• Immunic, Inc. (company) — subject company, pharmaceutical preparations
• 8,899,418 (dollar_amount) — shares beneficially owned
• 9.9% (dollar_amount) — percentage of class outstanding
• January 4, 2024 (person) — date of event requiring filing
• Delaware (company) — place of organization for Avidity Partners

Forward-Looking Statements

• Immunic's stock price may experience increased investor interest and potentially upward momentum due to Avidity Partners' significant stake. (Immunic, Inc.) — medium confidence, target: Q1 2024

FAQ

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securiti

Filing Documents

• d10934644_13g.htm (SC 13G) — 165KB
• 0000919574-24-000383.txt ( ) — 167KB

From the Filing

SC 13G 1 d10934644_13g.htm UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* Immunic, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 4525EP101 (CUSIP Number) January 4, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 4525EP101 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Avidity Partners Management LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 8,899,418 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 8,899,418 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,899,418 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.9% 1 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA, PN 1 The percentage of ownership based on 45,145,383 shares of Common Stock of the Company outstanding as of November 13, 2023, as reported on the Issuer’s Form S-3 filed on November 22, 2023, as adjusted for shares issued in the private placement described in the Issuer’s 8-K filed on January 5, 2024. CUSIP No. 4525EP101 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Avidity Partners Management (GP) LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 8,899,418 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 8,899,418 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,899,418 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.9% 2 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO 2 The percentage of ownership based on 45,145,383 shares of Common Stock of the Company outstanding as of November 13, 2023, as reported on the Issuer’s Form S-3 filed on November 22, 2023, as adjusted for shares issued in the private placement described in the Issuer’s 8-K filed on January 5, 2024. CUSIP No. 4525EP101 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Avidity Capital Partners Fund (GP) LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 8,899,418 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 8,899,418 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,899,418 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.9% 3 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO, PN 3 The percentage of ownership based on 45,145,383 shares of Common Stock of the Company outstanding as of November 13, 2023, as reported on the Issuer’s Form S-3 filed on November 22, 2023, as adjusted for shares issued in the private placement described in the Issuer’s 8-K filed on January 5, 2024. CUSIP No. 4525EP101 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Avidity Capital Partners (GP) LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WI

View Full Filing

View this SC 13G filing on SEC EDGAR